PATENT CLAIM ANALYSIS

Application Number: 16074589
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "381000"]

Abstract:
The present invention relates to methods and pharmaceutical compositions for treating heart failure in a pediatric human patient comprising administration to said patient of a therapeutically effective amount or a prophylactically effective amount of a combination of a therapeutic agent blocking the angiotensin receptor and a therapeutic agent inhibiting the NEP enzyme, in particular of a combination of sacubitril and valsartan in a pharmaceutically acceptable form and in a 1:1 molar ratio.

Claim (Index 5):
The method according to  claim 1 , wherein the patient has a systemic left ventricular ejection fraction (LVEF) of \u226440%, preferably \u226435, or fractional shortening of \u226420%.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 96.0
- Lexical Diversity: 1.54167
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15755733', '15345941', '14422855', '16046531', '15735717']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7902953304508564
- 35 USC 102 Novelty (BERT): 0.536743282326943
- Combined Prediction Score: 0.7649401256384651
- Mean Citation Score: 288.3194660000001
- Max Citation Score: 371.24084
- Similarity Product: 203.9301223811269

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test